19:00 Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology (news.google.com)
用中文浏览国外财经相关新闻
本站并非官方网站,仅对标题进行聚合翻译,点击即跳转至原站,所有内容版权归原站所有。本站无意做 SEO 垃圾站,只是为了方便快速发现感兴趣的外语文章。